LE WE PMID CA
Clopidogrel560Clopidogrel

ABCB1 P glycoprotein

Acetylsalicylic acid Aspirin

Cangrelor

Clopidogrel

CYP2C19

Heart (Atrial fibrillation)

Heart (Coronary heart disease BASKET)

P2Y12

Platelets (BASKET)

Prasugrel

Thrombotic thrombocytopenic purpura

Ticagrelor

Ticlopidine

2009  
1
An appraisal of dual antiplatelet therapy with clopidogrel and aspirin for prevention of cardiovascular events.
[19124633] J Am Board Fam Med 22(1): 51-6 (2009)
2010  
2
Proton pump inhibitors and clopidogrel.
[20345494] Cardiovasc Ther 28(3): 169-76 (2010)
2010  
3
Modern role for clopidogrel in management of atrial fibrillation and stroke reduction.
[20234784] Vasc Health Risk Manag 6(-): 95-103 (2010)
2009  
4
Proton pump inhibitors and clopidogrel - hazardous drug interaction or hazardous interpretation of data?
[19373416] Can J Gastroenterol 23(4): 251-2 (2009)
2009  
5
The present state of aspirin and clopidogrel resistance.
[19644597] Hamostaseologie 29(3): 285-90 (2009)
2008  
6
[Methods to evaluate aspirin and clopidogrel resistance].
[18278165] Hamostaseologie 28(1-2): 66-71 (2008)
2006  
7
[Resistance to acetylsalicylic acid and clopidogrel: current status].
[16906241] Hamostaseologie 26(3): 229-38 (2006)
1998  
8
The antiplatelet effects of ticlopidine and clopidogrel.
[9735068] Ann Intern Med 129(5): 394-405 (1998)
2006  
9
Clopidogrel pharmacogenetics: promising steps towards patient care?
[16857956] Arterioscler Thromb Vasc Biol 26(8): 1681-3 (2006)
2004  
10
Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistance.
[15388526] Arterioscler Thromb Vasc Biol 24(11): 1980-7 (2004)
2008  
11
Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
[18574266] Chest 133(6 Suppl): 199S-233S (2008)
2004  
12
Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
[15383474] Chest 126(3 Suppl): 234S-264S (2004)
1998  
13
Platelet-active drugs: the relationships among dose, effectiveness, and side effects.
[9822058] Chest 114(5 Suppl): 470S-488S (1998)
2005  
14
Loading, pretreatment, and interindividual variability issues with clopidogrel dosing.
[15911717] Circulation 111(20): 2557-9 (2005)
2008  
15
Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients.
[18826988] Eur Heart J 29(23): 2877-85 (2008)
2006  
16
Aspirin and clopidogrel resistance: an emerging clinical entity.
[16364973] Eur Heart J 27(6): 647-54 (2006)
2001  
17
2009  
18
Risk and benefit of proton pump inhibitor for patients undergoing anti-platelet therapy including clopidogrel.
[19881232] Intern Med 48(21): 1847-8 (2009)
2009  
19
Japan aims toward appropriate concomitant use of antiplatelets and antisecretory agents?
[19881231] Intern Med 48(21): 1845-6 (2009)
2004  
20
Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
[15494585] JAMA 292(15): 1867-74 (2004)
2009  
21
Expanding the recognition and assessment of bleeding events associated with antiplatelet therapy in primary care.
[19181649] Mayo Clin Proc 84(2): 149-60 (2009)
2008  
22
Aspirin and clopidogrel response variability: review of the published literature.
[18941611] Tex Heart Inst J 35(3): 313-20 (2008)
2008  
23
Clopidogrel and calcium-channel antagonists: another drug-drug interaction for the ever-wary clinician?
[19007593] J Am Coll Cardiol 52(19): 1564-6 (2008)
2008  
24
Omeprazole: a possible new candidate influencing the antiplatelet effect of clopidogrel.
[18206733] J Am Coll Cardiol 51(3): 261-3 (2008)
2007  
25
Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives.
[17418288] J Am Coll Cardiol 49(14): 1505-16 (2007)
2005  
26
Resistance to clopidogrel: a review of the evidence.
[15837243] J Am Coll Cardiol 45(8): 1157-64 (2005)
2011  
27
Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis.
[21816733] BMJ 343(-): d4588 (2011)
2004  
28
Clopidogrel resistance: a new chapter in a fast-moving story.
[15226220] Circulation 109(25): 3064-7 (2004)
2010  
29
Genotyping, clopidogrel metabolism, and the search for the therapeutic window of thienopyridines.
[20083686] Circulation 121(4): 481-3 (2010)
2009  
30
Proton pump inhibitors and clopidogrel: putting the interaction in perspective.
[19933929] Circulation 120(23): 2310-2 (2009)
2009  
31
P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use.
[19633016] Eur Heart J 30(16): 1964-77 (2009)
2004  
32
Editorial comment--an approach to the estimation of the risk of TTP during clopidogrel therapy.
[14757895] Stroke 35(2): 537-8 (2004)
2009  
33
Optimizing antiplatelet therapy in high-risk patients with atrial fibrillation: insights from Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE A).
[19875732] Stroke 40(12): 3883-5 (2009)
2007  
34
2011  
35
Clopidogrel resistance: current aspects and future directions.
[21642072] Hellenic J Cardiol 52(3): 236-45 (2011)
2010  
36
Clopidogrel and cardiovascular diseases: recommendations for its correct use.
[20118052] Hellenic J Cardiol 51(1): 83-6 (2010)
2007  
37
Resistance to aspirin and clopidogrel: possible mechanisms, laboratory investigation, and clinical significance.
[18196658] Hellenic J Cardiol 48(6): 352-63 (2007)
2010  
38
Aspirin and clopidogrel resistance: methodological challenges and opportunities.
[20448796] Vasc Health Risk Manag 6(-): 109-12 (2010)
2011  
39
Clinical evidence of interaction between clopidogrel and proton pump inhibitors.
[21666816] World J Cardiol 3(5): 153-64 (2011)
2011  
40
Genetic determinants of platelet response to clopidogrel.
[21706290] J Thromb Thrombolysis 32(4): 459-66 (2011)
2011  
41
CYP2C19 and ABCB1 genes and individualized treatment with clopidogrel.
[21332306] Pharmacogenomics 12(2): 141-4 (2011)
2010  
42
The potential interaction between clopidogrel and proton pump inhibitors: a systematic review.
[21134261] BMC Med 8(): 81 (2010)
PMC   
43
Clopidogrel resistance - a clear problem with an unclear solution.
[22929816] Indian Heart J 64(4):353-5 (2012)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.



Search PubMed and many other databases on the combined search terms

GG: clopidogrel

  • Clopidogrel

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia